Brazikumab Antibody
Brazikumab (AMG 139) is a humanized monoclonal antibody and selective IL-23 antagonist that binds the p19 subunit. It is a research tool for investigating Crohn's disease pathogenesis, with applications in both in vitro mechanistic studies and in vivo preclinical models.
Product Specifications
Product Name Alternative
MEDI 2070, MEDI2070, AMG139, AMG 139
Target
IL Receptor, Interleukin
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Concentration
5.98 mg/mL
Purity
95.00% (May vary between batches)
Molecular Weight
145.78 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
Tnfsf9-7445RAF647 20 μg- 50 μg- 100 μg
Recombinant Rat Tnfsf9 Protein, Fc-tagged, Alexa Fluor 647 conjugated
Sign In for Pricing
View Details 
MBS6152768-01 0.1 mL
GRID1 (Glutamate Receptor delta-1 Subunit, Glutamate Receptor Ionotropic delta 1, GluR delta-1 Subunit, KIAA1220) (HRP)
Sign In for Pricing
View Details MBS6152768-02 5x 0.1 mL
GRID1 (Glutamate Receptor delta-1 Subunit, Glutamate Receptor Ionotropic delta 1, GluR delta-1 Subunit, KIAA1220) (HRP)
Sign In for Pricing
View Details ICH6015-10mg 10 mg (2x 5 mg)
Ivonescimab Biosimilar - Research Grade
Sign In for Pricing
View Details 
MBS1186940-01 0.05 mg (E-Coli)
Recombinant Erwinia tasmaniensis Chorismate--pyruvate lyase (ubiC)
Sign In for Pricing
View Details MBS1186940-02 0.2 mg (E-Coli)
Recombinant Erwinia tasmaniensis Chorismate--pyruvate lyase (ubiC)
Sign In for Pricing
View Details